Literature DB >> 11917294

Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells.

David J Grdina1, Jeffrey S Murley, Yasushi Kataoka, Douglas P Calvin.   

Abstract

The effects of WR1065 (SH), the free thiol form of amifostine, on nuclear transcription factor kappaB (NFkappaB) activation, manganese superoxide dismutase (MnSOD) gene expression, and secretion of human vascular endothelial cell growth factor (hVEGF), basic fibroblast growth factor (bFGF), tumor necrosis factor-alpha (TNF-alpha), vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), E-selectin, P-selectin, and interleukins IL-1alpha, IL-6, and IL-8 were investigated and compared in human microvascular endothelial (HMEC) and human glioma cells. WR1065 was evaluated at 2 concentrations, 4 mmol/L, ie, its most effective cytoprotective dose, and 40 micromol/L, a noncytoprotective but highly effective dose capable of preventing radiation and chemotherapeutic drug-induced mutations in exposed cells. A 30-minute exposure of HMEC and glioma cell lines U87 and U251 to WR1065 at either of the concentrations resulted in a marked activation of NFkappaB as determined by a gel shift assay, with the maximum effect observed between 30 minutes and 1 hour after treatment. Using a supershift assay, WR1065 exposure was observed to affect only the p50-p65 heterodimer, and not the homodimers or heterodimers containing p52 or c-Rel subunits of NFkappaB. WR1065 was also found to enhance MnSOD gene expression in both HMEC and glioma cells. Gene expression was enhanced 1.8-fold over control levels in HMEC over a period ranging from 12 to 24 hours after the time of maximum activation of NFkappaB. In contrast, MnSOD gene expression in U87 cells rose 3.5 times above control levels over this same period. WR1065 had no effect on the levels of adhesion molecules, cytokines, and growth factors secreted by cells exposed for up to 24 hours as measured by enzyme-linked immunosorbent assay. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11917294     DOI: 10.1053/srao.2002.31383

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  8 in total

1.  Administration of rat acute-phase protein α(2)-macroglobulin before total-body irradiation initiates cytoprotective mechanisms in the liver.

Authors:  Desanka Bogojević; Goran Poznanović; Nevena Grdović; Ilijana Grigorov; Melita Vidaković; Svetlana Dinić; Mirjana Mihailović
Journal:  Radiat Environ Biophys       Date:  2010-09-17       Impact factor: 1.925

Review 2.  MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx.

Authors:  Demet Candas; Jian Jian Li
Journal:  Antioxid Redox Signal       Date:  2013-06-08       Impact factor: 8.401

3.  Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065.

Authors:  Jeffrey S Murley; Yasushi Kataoka; Christine J Weydert; Larry W Oberley; David J Grdina
Journal:  Free Radic Biol Med       Date:  2005-11-21       Impact factor: 7.376

Review 4.  NF-kappa B-mediated adaptive resistance to ionizing radiation.

Authors:  Kazi Mokim Ahmed; Jian Jian Li
Journal:  Free Radic Biol Med       Date:  2007-10-10       Impact factor: 7.376

5.  Amifostine reduces lung vascular permeability via suppression of inflammatory signalling.

Authors:  P Fu; A A Birukova; J Xing; S Sammani; J S Murley; J G N Garcia; D J Grdina; K G Birukov
Journal:  Eur Respir J       Date:  2008-11-14       Impact factor: 16.671

6.  WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication.

Authors:  Dale M Walker; Adriana E Kajon; Salina M Torres; Meghan M Carter; Consuelo L McCash; James A Swenberg; Patricia B Upton; Andrew W Hardy; Ofelia A Olivero; Gene M Shearer; Miriam C Poirier; Vernon E Walker
Journal:  Environ Mol Mutagen       Date:  2009-07       Impact factor: 3.216

Review 7.  Radioprotection.

Authors:  Joel S Greenberger
Journal:  In Vivo       Date:  2009 Mar-Apr       Impact factor: 2.155

Review 8.  Heavy ions, radioprotectors and genomic instability: implications for human space exploration.

Authors:  Jaroslaw Dziegielewski; Wilfried Goetz; Janet E Baulch
Journal:  Radiat Environ Biophys       Date:  2009-12-25       Impact factor: 1.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.